So much for the meritocracy myth on Wall Street. According to a recent study...the top five executives at the 20 banks receiving the largest amount of federal bailout dollars took home an average of almost $13.8 million in personal compensation last year – or 37% more than the average leader of an S&P 500 company. This most recent revelation underscores that rewards on Wall Street are completely disconnected from job performance.
Making money is not hard, but keeping it is. That's why top traders maintain three beliefs when it comes to money management.
Central bank decisions aside, the current market environment remains driven by risk sentiment, which brings us to tomorrow's July U.S. NFP report. The optimism is palpable that we'll see a more meaningful decline in jobs being shed, so the risks seem tilted to disappointment, which may come from an above consensus rise in the unemployment rate judging by the new cycle low in the Conference Board's labor differential, writes Brian Dolan, Chief Currency Strategist at FOREX.com
Major League Baseball is announcing this morning that it has signed an exclusive trading card deal with Topps. In an article commenting on the deal, Michael Eisner, who acquired the company two years ago, told the New York Times that the exclusive deal would lead to "redirecting the entire category towards kids." Baseball's executive vice president for business Tim Brosnan also mentioned how important it was to get kids back into the game
Everyone can achieve inner greatness. The key is to set goals. And while that may seem obvious, there are very few people out there who understand how to do this properly. For that reason, I've created a five-step process called C.H.A.M.P.
The recent financial struggles of two formerly great athletes are a reminder that risk management is vitally important, no matter how much money you have.
Newly confirmed FDA Commissioner Dr. Peggy Hamburg has got her work cut out for her. The FDA is responsible for policing a wide array of consumer goods, from foods and pharmaceuticals to cosmetics and medical devices...the agency has limited resources, so she’ll have to identify policies that can do the most for the greatest number of Americans, writes Peter Pitts a former Associate Commissioner for External Relations at the FDA.
Many times over the past several months, I have opened a newspaper or tuned into a show to hear opponents of health care reform say that it’s not that they oppose universal health care – they just don’t want to pay for it. Why, they argue, should they have to pay higher taxes when they are perfectly satisfied with the way the current system benefits them?